At a glance
- Originator Fujisawa
- Class Anti-inflammatories
- Mechanism of Action Cholecystokinin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pancreatitis
Most Recent Events
- 24 Aug 2001 No-Development-Reported for Pancreatitis in Japan (Unknown route)
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 30 Jan 1998 New profile